Brazil-focused private equity firm Gávea Investimentos sold shares worth BRL690 million (approximately US$221 million) in Brazil-based medical laboratory Instituto Hermes Pardini in the company’s IPO on Novo Mercado, a segment of BM&F BOVESPA. Gávea originally acquired a 30 percent stake in the company in 2011 through GIF IV.